A detailed history of South State Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, South State Corp holds 64,747 shares of AZN stock, worth $4.36 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
64,747
Previous 63,722 1.61%
Holding current value
$4.36 Million
Previous $4.97 Million 1.53%
% of portfolio
0.35%
Previous 0.36%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.67 - $87.62 $78,586 - $89,810
1,025 Added 1.61%
64,747 $5.05 Million
Q2 2024

Aug 02, 2024

SELL
$66.81 - $80.83 $17,838 - $21,581
-267 Reduced 0.42%
63,722 $4.97 Million
Q1 2024

May 06, 2024

BUY
$61.03 - $69.57 $104,239 - $118,825
1,708 Added 2.74%
63,989 $4.34 Million
Q4 2023

Feb 06, 2024

SELL
$61.89 - $69.28 $14,049 - $15,726
-227 Reduced 0.36%
62,281 $4.19 Million
Q3 2023

Nov 07, 2023

SELL
$64.85 - $71.7 $11,867 - $13,121
-183 Reduced 0.29%
62,508 $4.23 Million
Q2 2023

Aug 08, 2023

SELL
$69.91 - $75.81 $35,234 - $38,208
-504 Reduced 0.8%
62,691 $4.49 Million
Q1 2023

May 08, 2023

SELL
$63.15 - $71.6 $55,445 - $62,864
-878 Reduced 1.37%
63,195 $4.39 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $28,351 - $36,840
523 Added 0.82%
64,073 $4.34 Million
Q3 2022

Nov 07, 2022

SELL
$53.02 - $135.75 $202,218 - $517,750
-3,814 Reduced 5.66%
63,550 $3.49 Million
Q2 2022

Aug 05, 2022

SELL
$59.26 - $71.14 $240,417 - $288,614
-4,057 Reduced 5.68%
67,364 $4.45 Million
Q1 2022

May 06, 2022

BUY
$55.72 - $67.12 $25,352 - $30,539
455 Added 0.64%
71,421 $4.74 Million
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $172,755 - $204,128
-3,198 Reduced 4.31%
70,966 $4.13 Million
Q3 2021

Nov 10, 2021

BUY
$55.56 - $60.79 $21,390 - $23,404
385 Added 0.52%
74,164 $4.45 Million
Q2 2021

Aug 10, 2021

SELL
$48.42 - $60.18 $75,970 - $94,422
-1,569 Reduced 2.08%
73,779 $4.42 Million
Q1 2021

May 12, 2021

SELL
$47.16 - $54.44 $105,166 - $121,401
-2,230 Reduced 2.87%
75,348 $3.75 Million
Q4 2020

Feb 10, 2021

SELL
$48.52 - $58.02 $237,165 - $283,601
-4,888 Reduced 5.93%
77,578 $3.88 Million
Q3 2020

Nov 10, 2020

BUY
$53.07 - $61.1 $266,464 - $306,783
5,021 Added 6.48%
82,466 $4.52 Million
Q2 2020

Aug 11, 2020

BUY
$43.1 - $55.31 $517,674 - $664,328
12,011 Added 18.36%
77,445 $4.1 Million
Q1 2020

May 04, 2020

BUY
$37.79 - $51.33 $440,858 - $598,815
11,666 Added 21.7%
65,434 $2.92 Million
Q4 2019

Feb 05, 2020

BUY
$42.46 - $50.46 $174,298 - $207,138
4,105 Added 8.27%
53,768 $2.68 Million
Q3 2019

Nov 08, 2019

SELL
$40.12 - $45.47 $63,349 - $71,797
-1,579 Reduced 3.08%
49,663 $2.21 Million
Q2 2019

Aug 13, 2019

BUY
$37.28 - $41.68 $10,736 - $12,003
288 Added 0.57%
51,242 $2.12 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $105,405 - $127,769
2,970 Added 6.19%
50,954 $2.06 Million
Q4 2018

Feb 11, 2019

SELL
$36.86 - $41.49 $2.03 Million - $2.29 Million
-55,077 Reduced 53.44%
47,984 $1.82 Million
Q3 2018

Nov 08, 2018

BUY
$34.76 - $39.72 $301,299 - $344,292
8,668 Added 9.18%
103,061 $4.08 Million
Q2 2018

Aug 03, 2018

BUY
$34.55 - $37.05 $995,247 - $1.07 Million
28,806 Added 43.92%
94,393 $3.31 Million
Q1 2018

May 11, 2018

BUY
$32.97 - $36.63 $2.16 Million - $2.4 Million
65,587 New
65,587 $2.29 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $209B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.